Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Adenosine 3 mg/mL in 10 mL Injection, single dose vial Sanofi Winthrop Industrie, Notre Dame de Bondeville, France Adenoscan Miconazole nitrate 20 mg/g in 100 g Spray, powder, topical Ensign Laboratories Pty Limited, Mulgrave, Victoria, Australia Daktarin Lenograstim 105 mcg Powder for injection, vial Chugai Pharmaceutical Co Limited, Utsunomiya, Tochigi, Japan Granocyte 13 Lenograstim 263 mcg Powder for injection, vial Chugai Pharmaceutical Co Limited, Utsunomiya, Tochigi, Japan Granocyte 34 Interferon alpha-2b; 1, 3, 5, 9, 10, 30 million IU and diluent Powder for injection, vial Schering Plough (Brinny) Chemical Co., Brinny Innishannon, County Cork, Ireland Intron-A Interferon alpha-2b; 18 million IU in 3 mL, 25 million IU in 2.5 mL Solution for injection, vial Schering Plough (Brinny) Chemical Co., Brinny Innishannon, Country Cork, Ireland Intron-A 7.5 mcg Haemophilus influenza type b purified capsular polysaccharide (polyribosylribitol phosphate PRP) and 125 mcg neisseria meningitidis OMPC per 0.5 mL Solution for injection, single dose vial Merck & Co Inc., West Point, Pennsylvania, United States of America Pedvax HIB Risperidone 1 mg/mL in 100 mL Solution, oral Janssen Pharmaceutica n v., Beerse, Belgium Risperdal Cefuroxime sodium equivalent to 250 mg, 750 mg 1.5 g cefuroxime Powder for injection, vial Glaxo Operations UK Limited, Barnard Castle, County Durham, United Kingdom Zinacef Cefuroxime axetil 125 mg, 250 mg, 500 mg Tablets Glaxo Operations UK Limited, Barnard Castle, County Durham, United Kingdom Zinnat Dated this 29th day of October 1996. KAREN O. POUTASI (Dr), Director-General of Health, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.